---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-117781"
form_type: "8-K"
ticker: "TTRX"
cik: "0002023016"
company_name: "Turn Therapeutics Inc."
filed_at: "2026-11-10T13:05:32+00:00"
generated_at: "2026-11-10T13:10:25.186050+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Turn Therapeutics (TTRX) posts updated investor presentation dated Nov 10, 2026; exhibit text lacks financial detail

## Summary
- Updated investor presentation dated November 10, 2026 released; no separate press release, earnings release or financial-data tables accompany it.
- The appended exhibit text contains only the cover slide and a forward-looking-statements safe-harbor page; no revenue, cash, pipeline or trial data is legible.
- Signed by Chief Executive Officer Bradley Burnam on November 10, 2026; company is an emerging growth company.
- No operational, clinical, financial or guidance changes are disclosed in the readable text; investors must obtain the full deck from the company.

## SEC filing metadata
- accession: 0001213900-26-117781
- form_type: 8-K
- ticker: TTRX
- cik: 0002023016
- company_name: Turn Therapeutics Inc.
- filed_at: 2026-11-10T13:05:32+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2023016/000121390026117781/0001213900-26-117781-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2023016/000121390026117781/ea0311587-8k_turn.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-117781
- JSON: https://secwatch.observer/filing/0001213900-26-117781.json
- Plain text: https://secwatch.observer/filing/0001213900-26-117781.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.